HDAC6 α-tubulin deacetylase: A potential therapeutic target in neurodegenerative diseases (Q37850047)

24 August 2017

1 reference

title

HDAC6 α-tubulin deacetylase: a potential therapeutic target in neurodegenerative diseases (English)

1 reference

24 August 2017

HDAC6 α-tubulin deacetylase: A potential therapeutic target in neurodegenerative diseases (English)

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

26 November 2024

1 reference

Guoyi Li

1

1 reference

24 August 2017

Huiyi Jiang

2

1 reference

24 August 2017

Ming Chang

3

1 reference

24 August 2017

Hongrong Xie

4

1 reference

24 August 2017

Linsen Hu

5

1 reference

24 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21377170

26 November 2024

publication date

5 March 2011

1 reference

full work available at URL

24 August 2017

https://api.elsevier.com/content/article/PII:S0022510X11000724?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

https://api.elsevier.com/content/article/PII:S0022510X11000724?httpAccept=text/plain

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Journal of the Neurological Sciences

26 November 2024

published in

1 reference

24 August 2017

volume

304

1 reference

24 August 2017

issue

1-2

1 reference

24 August 2017

page(s)

1-8

1 reference

Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders.

24 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Therapeutic application of histone deacetylase inhibitors for central nervous system disorders

26 November 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation

26 November 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Two catalytic domains are required for protein deacetylation.

26 November 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Active maintenance of mHDA2/mHDAC6 histone-deacetylase in the cytoplasm

26 November 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor

26 November 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

HDAC6 modulates cell motility by altering the acetylation level of cortactin

26 November 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Isoform-selective histone deacetylase inhibitors.

26 November 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Acetylation and deacetylation of non-histone proteins

26 November 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Histone deacetylase inhibitors: gathering pace

26 November 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Histone deacetylase inhibitors: discovery and development as anticancer agents

26 November 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Inside HDAC with HDAC inhibitors

26 November 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Class II histone deacetylases: from sequence to function, regulation, and clinical implication

26 November 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

HDAC6 is a microtubule-associated deacetylase

26 November 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation

26 November 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo

26 November 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Identification of an acetylation site of Chlamydomonas alpha-tubulin

26 November 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Tubulin modifications and their cellular functions.

26 November 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates

26 November 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress

26 November 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin

26 November 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation

26 November 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease

26 November 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

HDAC6 is a target for protection and regeneration following injury in the nervous system

26 November 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Novel structural insights into class I and II histone deacetylases

26 November 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Crystal structure of a bacterial class 2 histone deacetylase homologue

26 November 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor

26 November 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors

26 November 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Three proteins define a class of human histone deacetylases related to yeast Hda1p

26 November 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Characterization of the two catalytic domains in histone deacetylase 6.

26 November 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Role of the tetradecapeptide repeat domain of human histone deacetylase 6 in cytoplasmic retention.

26 November 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways

26 November 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

HDAC6-p97/VCP controlled polyubiquitin chain turnover

26 November 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Histone deacetylase 6 binds polyubiquitin through its zinc finger (PAZ domain) and copurifies with deubiquitinating enzymes

26 November 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

HDAC6-pack: cortactin acetylation joins the brew

26 November 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions

26 November 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

26 November 2024

The tubulin code

40

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Post-translational modifications regulate microtubule function

26 November 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Microtubule modification: acetylation speeds anterograde traffic flow

26 November 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Microtubule acetylation promotes kinesin-1 binding and transport.

26 November 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking

26 November 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

A novel Rho-mDia2-HDAC6 pathway controls podosome patterning through microtubule acetylation in osteoclasts

26 November 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

An acetylation site in the middle domain of Hsp90 regulates chaperone function

26 November 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Aggresomes, inclusion bodies and protein aggregation

26 November 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Hassles with taking out the garbage: aggravating aggresomes.

26 November 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Ubiquitin-binding domains

26 November 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

AAA ATPase p97/VCP: cellular functions, disease and therapeutic potential

26 November 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Huntingtin interacts with the cue domain of gp78 and inhibits gp78 binding to ubiquitin and p97/VCP.

26 November 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Protein aggregation and neurodegenerative disease

26 November 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Collective roles of molecular chaperones in protein degradation pathways associated with neurodegenerative diseases

26 November 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?

26 November 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Autophagy induction rescues toxicity mediated by proteasome inhibition

26 November 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Parkin-mediated ubiquitin signalling in aggresome formation and autophagy

26 November 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy

26 November 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS

26 November 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

The aggresome pathway as a target for therapy in hematologic malignancies

26 November 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

The role of molecular chaperones in human misfolding diseases

26 November 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Hsp90: chaperoning signal transduction

26 November 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Disaggregating chaperones: an unfolding story.

26 November 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Protein degradation and protection against misfolded or damaged proteins

26 November 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties

26 November 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Hsp90: a chaperone for protein folding and gene regulation

26 November 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors.

26 November 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Regulation of the dynamics of hsp90 action on the glucocorticoid receptor by acetylation/deacetylation of the chaperone

26 November 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

On mechanisms that control heat shock transcription factor activity in metazoan cells

26 November 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Functional division of substrate processing cofactors of the ubiquitin-selective Cdc48 chaperone

26 November 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Inhibitors of HDACs--effective drugs against cancer?

26 November 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Identification of type-specific anticancer histone deacetylase inhibitors: road to success

26 November 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Multiple roles of HDAC inhibition in neurodegenerative conditions.

26 November 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.

26 November 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.

26 November 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Design, synthesis, structure--selectivity relationship, and effect on human cancer cells of a novel series of histone deacetylase 6-selective inhibitors

26 November 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Multidimensional chemical genetic analysis of diversity-oriented synthesis-derived deacetylase inhibitors using cell-based assays

26 November 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides

26 November 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer

26 November 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma

26 November 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Mercaptoamide-based non-hydroxamic acid type histone deacetylase inhibitors

26 November 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Chemistry and biology of mercaptoacetamides as novel histone deacetylase inhibitors

26 November 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Identification of a potent non-hydroxamate histone deacetylase inhibitor by mechanism-based drug design

26 November 2024

82

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Functional differences in epigenetic modulators-superiority of mercaptoacetamide-based histone deacetylase inhibitors relative to hydroxamates in cortical neuron neuroprotection studies

26 November 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Explorative study on isoform-selective histone deacetylase inhibitors

26 November 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Subtype selective substrates for histone deacetylases

26 November 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

HDAC6 at the intersection of autophagy, the ubiquitin-proteasome system and neurodegeneration

26 November 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

26 November 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6

26 November 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Disease-causing mutations in parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy

26 November 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

The ubiquitin-proteasome system in Alzheimer's disease

26 November 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease

26 November 2024

91

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments

26 November 2024

92

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Histone deacetylase 6 interacts with the microtubule-associated protein tau

26 November 2024

93

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Reduction of acetylated alpha-tubulin immunoreactivity in neurofibrillary tangle-bearing neurons in Alzheimer's disease

26 November 2024

94

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Tau--an inhibitor of deacetylase HDAC6 function

26 November 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration

26 November 2024

96

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

HDAC6 regulates mitochondrial transport in hippocampal neurons

26 November 2024

97

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Recovery of learning and memory is associated with chromatin remodelling

26 November 2024

98

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease

26 November 2024

99

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau

26 November 2024

100

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

26 November 2024

Huntington's disease

101

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

Disruption of Axonal Transport by Loss of Huntingtin or Expression of Pathogenic PolyQ Proteins in Drosophila

26 November 2024

102

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.017

26 November 2024

Identifiers

1 reference

24 August 2017

1 reference